宏源药业(301246.SZ)：布局电解液添加剂等产品，与六氟磷酸锂业务形成产业协同

Core Viewpoint - Hongyuan Pharmaceutical (301246.SZ) is strategically expanding its product offerings to include electrolyte additives and functional lithium salts, which will synergize with its lithium hexafluorophosphate business, thereby enhancing the scale and market competitiveness of its lithium battery segment [1]. Group 1 - The company is focusing on the development of electrolyte additives and functional lithium salts [1]. - This expansion is aimed at creating industrial synergy with its existing lithium hexafluorophosphate business [1]. - The initiative is expected to continuously improve the business scale and market competitiveness of the company's lithium battery sector [1].